Medical Xpress – No increased cancer risk with glargine versus human insulin

There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study published online July 22 in Diabetes Care.

Read more

Posted in Glucose & Insulin